About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts

Media Stories

2019 2018 2017 2016 2015

May 2019
23 May  Canada clears Mylon & Biocon's Biosimilar
20 May  Biologics to boost Biocon business. say analyst
9 May  Biocon drug gets commercial rights to global markets
April 2019
30 Apr  Biosimilars to help Biocon hit $1bn revenue in FY20
27 Apr  Biologics, research services the golden goose for Biocon
26 Apr  Biocon Q4 net profit up 64% to ₹213.7 crore
18 Apr  Kiran Mazumdar-Shaw conferred with honorary doctorate from Deakin University, Australia
12 Apr  Violence,EVM glitches, missing names:Rocky start to election
08 Apr  Research must be promoted in colleges
05 Apr  ET Prime celebrates Women's Excellence in Business & Innovation
05 Apr  Breakthrough innovation is taking place but we're not leveraging it
04 Apr  Kiran Mazumdar-Shaw conferred with Honorary Doctorate
01 Apr  Biocon Biologics India appoints Dr. Christiane Hamacher as CEO
March 2019
29 Mar  Biocon chief stresses on gender equality
19 Mar  Kiran back as Infy's independent director
18 Mar  Govt Should Scale Up Philanthropic Capital
15 Mar  Cost of select insulin increases up to 20%
12 Mar  Role of Indian women in Science & Technology
11 Mar  The growing share of biosimilars revenue is doing wonders for our business
08 Mar  Biosimilars offer a huge opportunity for Biocon
07 Mar  Future jobs will be different: Shaw
03 Mar  Pharma specialist new CEO of Biocon Biologics
02 Mar  Hamacher is CEO of Biocon Biologics
February 2019
28 Feb  In bid to curb profiteering, govt caps margins of 42 cancer drugs
23 Feb  Shortage of women for leadership roles
18 Feb  Biocon's revenue up 43%; Net profit up 136%
13 Feb  Biocon's Trastuzumab receives approvals in EU
09 Feb  Kiran Mazumdar-Shaw elected member of US-based NAE
04 Feb  Socio-Economic Issues Focus Area of Budget 2019
02 Feb  Budget Quotes
01 Feb  Biocon, Mylan announce positive CHMP opinion for Fulphila
January 2019
31 Jan  Why Quitting Should Never Be An Option
29 Jan  Stock Reccos
28 Jan  Biosimilars make Biocon stand apart
25 Jan  Biocon Dec quarter net zooms over two-fold to ₹217 Cr
20 Jan  Top-ranked Karnataka doubles down on skill development
16 Jan  Biocon focus may shift to non-insulins
13 Jan  A Briefcase and A Baby
12 Jan  Kiran Mazumdar-Shaw gets second term as Infosys' Lead Independent Director
07 Jan  For India's healthy billion





Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer            © 2018, Biocon. All Rights Reserved